The gap between dyslipidemia control perceived by physicians and objective control patterns in Spain

被引:37
作者
Banegas, Jose R.
Vegazo, Onofre
Serrano, Pedro
Luengo, Emilio
Mantilla, Teresa
Fernandez, Raul.
Civeira, Fernando
机构
[1] Univ Autonoma Madrid, Fac Med, Dept Med Prevent & Salud Publ, E-28029 Madrid, Spain
[2] Hosp Clin Lozano Blesa, Serv Cardiol, Zaragoza, Spain
[3] Hosp Gen Def, Serv Cardiol, Zaragoza, Spain
[4] Inst Madrileno Salud, Primary Care Hlth Ctr Mar Baltico, Madrid, Spain
[5] Hosp Univ Miguel Servet, Serv Internal Med, Zaragoza, Spain
关键词
dyslipidemia; treatment goals; guidelines; control;
D O I
10.1016/j.atherosclerosis.2005.11.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: It is well-known that adequate control of dyslipidemia is low. But little is known about how well physicians perceive the control of their dyslipidemic patients. This study examines physicians' subjective perception of dyslipidemia control, and compares it with control determined objectively with published guidelines. Methods: A total of 33,913 patients were studied cross-sectionally in 164 Spanish outpatients' clinics. Of these patients, 5583 were evaluable patients with a documented diagnosis of dyslipidemia. Control of dyslipidemia was evaluated by two methods: the physician's opinion on their patient's lipid levels (adequate control or inadequate control), and the proportion of patients who objectively reach the LDL-cholesterol goals of the National Cholesterol Education Program (NCEP/ATPIII). Results: Physicians perceived that 44% (95% CI 42.7-45.3%) of their patients had an adequate control of their dyslipidemia, but only 32.8% (95% CI 31.6-34.0%) were objectively controlled. Subjective control hardly changed across the NCEP cardiovascular risk groups, but objective control was lower in the 2372 coronary heart disease patients (15.1%) and in the 1407 moderately high-risk patients (29.6%) than in the 1804 lower risk patients (58.5%). Physicians' perception of control was significantly and independently associated with objective control (P < 0.001). Conclusions: Physicians overestimate dyslipidemia control in the majority of their patients. Misperception. of control by physicians may contribute to the low achievement of objective control. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:420 / 424
页数:5
相关论文
共 11 条
[1]   Why don't physicians follow clinical practice guidelines? A framewouk for improvement [J].
Cabana, MD ;
Rand, CS ;
Powe, NR ;
Wu, AW ;
Wilson, MH ;
Abboud, PAC ;
Rubin, HR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (15) :1458-1465
[2]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[3]   Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults - Findings from the National Health and Nutrition Examination Survey, 1999 to 2000 [J].
Ford, ES ;
Mokdad, AH ;
Giles, WH ;
Mensah, GA .
CIRCULATION, 2003, 107 (17) :2185-2189
[4]   A new reality: achieving cholesterol-lowering goals in clinical practice [J].
Gaw, A .
ATHEROSCLEROSIS SUPPLEMENTS, 2002, 2 (04) :5-11
[5]  
Gómez J, 2000, CLIN DRUG INVEST, V19, P131
[6]  
*MIN SAN CONS, 2003, ATL SAN ESP
[7]   The Lipid Treatment Assessment Project (L-TAP) -: A multicenter survey to evaluate the percentages of dyslipidemic, patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals [J].
Pearson, TA ;
Laurora, I ;
Chu, H ;
Kafonek, S .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (04) :459-467
[8]   Clinical inertia [J].
Phillips, LS ;
Branch, WT ;
Cook, CB ;
Doyle, JP ;
El-Kebbi, IM ;
Gallina, DL ;
Miller, CD ;
Ziemer, DC ;
Barnes, CS .
ANNALS OF INTERNAL MEDICINE, 2001, 135 (09) :825-834
[9]   Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional survey [J].
Primatesta, P ;
Poulter, NR .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7272) :1322-1325
[10]  
Schwandt Peter, 2004, Expert Rev Cardiovasc Ther, V2, P431, DOI 10.1586/14779072.2.3.431